When you’re prescribed antibiotics, you might wonder if taking probiotics will safeguard your microbiome. It’s a common suggestion from friends and family. However, research indicates that probiotic supplements may not provide the benefits you’re hoping for. In fact, they could potentially hinder your recovery process. Understanding Probiotics and Antibiotics Probiotics are live bacteria intended to […]
“I have lung cancer?” I asked my doctor, disbelief evident in my voice as I processed the news over the phone. “I am afraid so,” he confirmed. After the call, my surroundings seemed frozen in time. I went straight to my husband Jimmy’s office, desperate for clarity. “It’s cancer,” I told him, still in shock. […]
The development of a new Ebola vaccine is nearing a crucial phase. This vaccine is unique, targeting the Bundibugyo strain of Ebola. Prior vaccines focused on other strains. Although human trials have not begun, the news offers hope. The effectiveness of the vaccine can change the course of future Ebola outbreaks.
New research suggests that glucagon-like peptide-1 (GLP-1) weight-loss medications might help slow the spread of certain obesity-related cancers. A study led by the Cleveland Clinic indicates these drugs could affect lung, breast, colorectal, and liver cancers. The findings will be presented at the 2026 ASCO Annual Meeting in Chicago. Study Details and Findings The retrospective […]
Recent research by the Alzheimer’s Association suggests that a person’s biological age, derived from a blood test, might indicate their risk of developing dementia. Study Overview Researchers in the United Kingdom analyzed data from the UK Biobank, which included over 223,000 participants. They focused on blood metabolites, which are small molecules associated with fat processing, […]
The FDA is fast-tracking the development of a promising new drug for pancreatic cancer known as daraxonrasib. This medication aims to block cancer signals associated with the RAS gene. It has completed an early-stage clinical trial, evaluating its safety and effectiveness for humans. Daraxonrasib was tested on 168 patients diagnosed with advanced pancreatic cancer who […]
A new treatment for endometrial cancer has shown strong potential in a Phase 3 clinical trial. Drugmaker Merck announced that their investigational drug, sacituzumab tirumotecan (sac-TMT), achieved its primary goals of overall survival and progression-free survival in patients with advanced or recurrent endometrial cancer. The TroFuse-005 trial stands as a landmark study, being the first […]